Cargando…
A gene signature predicting prognosis of patients with lower-grade gliomas receiving temozolomide therapy
Temozolomide (TMZ) has been used as a first-line therapy against lower-grade gliomas (LGGs) combined with other chemotherapy drugs. However, there has been no reliable index predicting TMZ response of patients with LGGs. In this study, we aim to investigate the relationship between gene expressions...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643648/ https://www.ncbi.nlm.nih.gov/pubmed/37955724 http://dx.doi.org/10.1007/s12672-023-00818-9 |